{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:28:22Z","timestamp":1788942502744,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Am J Phys Med Rehabil"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Facet joint interventions are commonly performed procedures in patients with neck and back pain, including patients managed with anticoagulant\/antiplatelet medications. Temporary cessation of anticoagulant\/antiplatelet medications may increase the risk of thromboembolic complications, which may be unnecessary.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of the study was to determine the risk of clinically relevant hemorrhagic complications in patients undergoing facet interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Consecutive patients from September 19, 2009, to June 16, 2017, who were on anticoagulant\/antiplatelet medication medications and scheduled for an any facet intervention in the cervical, thoracic, and lumbosacral spine were retrospectively audited for bleeding complications for a minimum of 90 days after procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five hundred eighty-two procedures targeting the cervical, thoracic, or lumbosacral facet joints were performed on patients on anticoagulant or antiplatelet medications. One hundred twenty-eight patients ceased their anticoagulant\/antiplatelet medications before the procedure and 454 maintained anticoagulant\/antiplatelet medications. No clinically relevant epidural hematomas were noted in the patient cohort (0\/582, 0%, 95% confidence interval = 0.0%\u20130.6%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion\/Conclusions<\/jats:title>\n                    <jats:p>The risk of clinically relevant bleeding complications including epidural hematoma in properly performed facet interventions is low. This information is crucial in being able to quantitatively determine the risk of ceasing or maintaining anticoagulant\/antiplatelet medications before cervical thoracic and lumbar facet interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/phm.0000000000002795","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T15:00:18Z","timestamp":1750950018000},"page":"28-32","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Epidural Hematoma Risks Associated With Ceasing Versus Maintaining Anticoagulant and\/or Antiplatelet Medications for Spine Facet Interventions"],"prefix":"10.1097","volume":"105","author":[{"given":"Michael B.","family":"Furman","sequence":"first","affiliation":[{"name":"OSS Health, York, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6644-0928","authenticated-orcid":false,"given":"Gene","family":"Tekmyster","sequence":"additional","affiliation":[{"name":"Keck Medicine of USC, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelia","family":"Gilhool","sequence":"additional","affiliation":[{"name":"OSS Health, York, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse S.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Monterey Spine and Joint, Monterey, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay R.","family":"Kurup","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Lenox Hill Hospital, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Bednarek","sequence":"additional","affiliation":[{"name":"Clearway Pain Solutions Institute, Annapolis, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holden M.","family":"Caplan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Maryland Medical Center, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Schneider","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"bib1-20251212","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/pm\/pnw051","article-title":"Immediate adverse events in interventional pain procedures: a multi-institutional study","volume":"17","year":"2016","journal-title":"Pain Med"},{"key":"bib2-20251212","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/euab303","article-title":"Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis","volume":"24","year":"2022","journal-title":"Europace"},{"key":"bib3-20251212","doi-asserted-by":"crossref","first-page":"e026723","DOI":"10.1161\/JAHA.122.026723","article-title":"Trends in oral anticoagulant use among 436 864 patients with atrial fibrillation in community practice, 2011 to 2020","volume":"11","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"bib4-20251212","first-page":"1218","article-title":"Anticoagulant and antiplatelet management for spinal procedures: a prospective, descriptive study and interpretation of guidelines","volume":"187","year":"2017","journal-title":"Pain Med"},{"key":"bib5-20251212","first-page":"225","article-title":"Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications (SECOND EDITIOn): guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain","volume":"43","year":"2018","journal-title":"Reg Anesth Pain Med"},{"key":"bib6-20251212","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/AAP.0000000000000223","article-title":"Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain","volume":"40","year":"2015","journal-title":"Reg Anesth Pain Med"},{"key":"bib7-20251212","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/pm\/pnw108","article-title":"The risks of continuing or discontinuing anticoagulants for patients undergoing common interventional pain procedures","volume":"18","year":"2017","journal-title":"Pain Med"},{"key":"bib8-20251212","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/pm\/pnx152","article-title":"Risks and benefits of ceasing or continuing anticoagulant medication for image-guided procedures for spine pain: a systematic review","volume":"19","year":"2018","journal-title":"Pain Med"},{"key":"bib9-20251212","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/pm\/pnaa009","article-title":"Antiplatelet and anticoagulant risk for select spine interventions: a retrospective cohort","volume":"21","year":"2020","journal-title":"Pain Med"},{"key":"bib10-20251212","first-page":"2084","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation","volume":"268","year":"2013","journal-title":"N Engl J Med"},{"key":"bib11-20251212","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jacc.2014.11.060","article-title":"Cost effectiveness of continued- warfarin versus haparin-bringing therapy during pacemaker and defibrillator surgery","volume":"65","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"bib12-20251212","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.hrthm.2010.12.016","article-title":"Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial","volume":"8","year":"2011","journal-title":"Heart Rhythm"},{"key":"bib13-20251212","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.joms.2008.12.027","article-title":"Randomized, prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during extraction of teeth","volume":"67","year":"2009","journal-title":"J Oral Maxillfac Surg"},{"key":"bib14-20251212","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0161-6420(03)00785-1","article-title":"Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery","volume":"110","year":"2003","journal-title":"Ophthalmology"},{"key":"bib15-20251212","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40122-023-00476-3","article-title":"Impact of the COVID-19 pandemic on utilization patterns of facet joint interventions in managing spinal pain in a Medicare population","volume":"12","year":"2023","journal-title":"Pain Ther"},{"key":"bib18-20251212","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"bib19-20251212","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/CIRCULATIONAHA.113.005754","article-title":"Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin k antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)","volume":"129","year":"2014","journal-title":"Circulation"},{"key":"bib20-20251212","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"bib21-20251212","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/STROKEAHA.110.611905","article-title":"Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence","volume":"42","year":"2011","journal-title":"Stroke"},{"key":"bib22-20251212","first-page":"317","article-title":"A prospective evaluation of bleeding risk of interventional techniques in chronic pain","volume":"14","year":"2011","journal-title":"Pain Physician"},{"key":"bib23-20251212","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00330-019-06483-3","article-title":"Intra-articular facet joint steroid injection-related adverse events encountered during 11,980 procedures","volume":"30","year":"2020","journal-title":"Eur Radiol"},{"key":"bib24-20251212","first-page":"100090","article-title":"Factfinders for patient safety: anticoagulant and antiplatelet agents and cervical medial branch procedures","volume":"1","year":"2022","journal-title":"Interv Pain Med"},{"key":"bib25-20251212","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1093\/pm\/pnaa311","article-title":"Anticoagulants and antiplatelets for lumbar medial branch blocks","volume":"21","year":"2020","journal-title":"Pain Med"},{"key":"bib26-20251212","first-page":"100008","article-title":"FactFinders for patient safety: antithrombotics and interventional pain procedures \u2013 lumbar transforaminal epidural steroid injections and lumbar medial branch radiofrequency neurotomy","volume":"1","year":"2021","journal-title":"Interv Pain Med"},{"key":"bib29-20251212","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pmrj.2014.04.012","article-title":"Should antiplatelet medications be held before cervical epidural injections?","volume":"6","year":"2014","journal-title":"PM R"},{"key":"bib30-20251212","first-page":"437","article-title":"Continuing anti-thrombotic medication during low-to-intermediate risk spinal procedures: a retrospective evaluation","volume":"20","year":"2017","journal-title":"Pain Physician"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000002795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:04:00Z","timestamp":1765548240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000002795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/phm.0000000000002795","relation":{},"ISSN":["1537-7385","0894-9115"],"issn-type":[{"value":"1537-7385","type":"electronic"},{"value":"0894-9115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"2025-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}